Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC

BACKGROUND & AIMS: Antiviral treatment is known to improve survival in patients with chronic hepatitis B (CHB)-related hepatocellular carcinoma (HCC). Yet, the treatment uptake in CHB patients remains low. We aimed to report the secular trend in antiviral treatment uptake from 2007–2017, and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Vicki Wing-Ki, Chan, Stephen Lam, Wong, Vincent Wai-Sun, Liang, Lilian Yan, Yip, Terry Cheuk-Fung, Lai, Jimmy Che-To, Yuen, Becky Wing-Yan, Luk, Hester Wing-Sum, Tse, Yee-Kit, Lee, Hye-Won, Chan, Henry Lik-Yuen, Wong, Grace Lai-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530304/
https://www.ncbi.nlm.nih.gov/pubmed/33024950
http://dx.doi.org/10.1016/j.jhepr.2020.100152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530304/
https://www.ncbi.nlm.nih.gov/pubmed/33024950
http://dx.doi.org/10.1016/j.jhepr.2020.100152

Ejemplares similares